The trial found no significant difference in hospitalization or death risk between patients using long-term oxygen therapy for 24 hours versus 15 hours per day, potentially offering more freedom for those with severe hypoxemia.

Northwestern Medicine’s women leaders in neurosciences are advancing research and patient care across various neurological subspecialties, from headache disorders to sleep medicine.

The Epitomee capsule, a novel ingestible device for weight management, has shown promising results in clinical trials, with 55.5% of users losing at least 5% of their baseline body weight at 24 weeks.

Primary CNS vasculitis affects an estimated 2.4 cases per 1 million person-years, presenting a significant diagnostic and therapeutic challenge for neurologists and rheumatologists.

Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.

Recent surveys indicate that 53% of physicians report feeling burned out, with female doctors experiencing higher rates than their male counterparts.